Future Market Insights8h
Global Human Growth Hormone Treatment and Drugs Market Poised for Steady Growth to Reach USD 5.26 Billion by 2033 at a CAGR of 3.7%
The global Human Growth Hormone Treatment and Drugs Market is expected to reach a value of around USD 5.26 billion by 2033, ...
Nature5y
HUMAN GROWTH HORMONE AND THE FDA BAN: PSYCHOLOGICAL IMPACT
In April, 1985, the FDA banned the distribution of pituitary growth hormone (hGH) because of the possibility that it was contaminated by a “slow virus”. All parents of children receiving hGH ...
Medical Xpress27d
Intranasal oxytocin shows promise for treating core symptom of frontotemporal dementia
Get Instant Summarized Text (Gist) Intranasal oxytocin shows potential in treating apathy, a core symptom of frontotemporal dementia (FTD), which affects behavior, language, and decision-making ...
Nature16d
HUMAN GROWTH HORMONE VARIANT (hGH-B) PROMOTES GROWTH IN TRANSGENIC MICE
The human growth hormone (hGH) gene family consists of 5 members linked on the long arm of chromosome 17. The hGH-A gene is expressed by the somatotrophs of the anterior pituitary. The hGH-B gene ...
BMJ5mon
Claims for the anabolic effects of growth hormone: a case of the Emperor’s new clothes?
Nasal sprays (of doubtful efficacy ... “Product X is a high concentration real Pharmaceutical Grade Recombinant Human Growth Hormone solution (2040 ng/ml.) The product comes with a patented delivery ...
Business Wire22d
Tris Pharma Reports Positive Clinical Results of Intranasal Human Abuse Potential Study Indicating Low Abusability of Cebranopadol, an Investigational, First-in-Class Oral Dual ...
today announced positive clinical data from its intranasal human abuse potential (HAP) study in subjects who are nondependent recreational opioid users, which demonstrate that cebranopadol ...